Contact – +1-276-477-5910
 Email – [email protected]

Home >>

Healthcare and Social Assistance

>>

Global Bioelectric Medicine Market


Global Bioelectric Medicine Market 2020-2030 by Product Type (Implantable, Non-invasive), End User, and Region: Trend Forecast and Growth Opportunity

Report code: SDMRHE1613145 | Industry: Healthcare and Social Assistance | Published On: 2022-01-07


Bioelectric medicines, also known as electroceuticals, are medical devices that are used to restore health in patients. Bioelectric medicines function through neurostimulation and modulation of the nervous systems through electrical impulses. Global bioelectric medicine market will reach $39.06 billion by 2030, growing by a revised CAGR of 7.3% over 2020-2030 driven by growing geriatric population and rising acceptance of bioelectric medicines.
Highlighted with 106 tables and 76 figures, this 201-page report “Global Bioelectric Medicine Market 2020-2030 by Product Type (Implantable, Non-invasive), End User, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global bioelectric medicine market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate/forecast from 2020 till 2030 with 2019 as the base year.
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global bioelectric medicine market in every aspect of the classification from perspectives of Product Type, End User, and Region.

Based on Product Type, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Implantable Bioelectric Medicine
o Cardiac Pacemaker
o Implantable Cardioverter Defibrillators (ICD)
o Spinal Cord Stimulators (split into Chronic Pain, Failed Back Syndrome (FBSS), Ischemia by application)
o Cochlear Implants
o Deep Brain Stimulators (split into Parkinson’s Disease, Tremor, Depression, Other Deep Brain Stimulation Applications by application)
o Vagus Nerve Stimulators
o Sacral Nerve Stimulators (split into Urinary Incontinence and Fecal Incontinence by application)
o Retinal Implants
o Other Implantable Bioelectric Medicines
• Non-invasive Bioelectric Medicine
o Transcutaneous Electrical Nerve Stimulators
o Transcranial Magnetic Stimulation (TMS)
o Pulsed Electromagnetic Field Therapy
o Other Non-invasive Bioelectric Medicines

Based on End User, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Hospitals and Clinics
• Research Institutes
• Individual Users

Geographically, the following regions together with the listed national/local markets are fully investigated:
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (Saudi Arabia, UAE, South Africa)
For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Product Type and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in global bioelectric medicine market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
Abbott Laboratories
BIOTRONIK SE & Co. KG
Boston Scientific Corporation
Cochlear Limited
electroCore, Inc.
Inspire Medical Systems, Inc.
LivaNova PLC
Medtronic PLC
NeuroMetrix, Inc
Nevro Corp.
Nuvectra Corporation
OMRON CORPORATION
Pixium Vision
Second Sight Medical Products Inc
SetPoint Medical
Sonova Holding AG
St. Jude Medical, Inc.
Stimwave LLC
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1  Introduction 9
1.1  Industry  Definition  and  Research  Scope 9
1.1.1  Industry  Definition 9
1.1.2  Research  Scope 10
1.2  Research  Methodology 13
1.2.1  Overview  of  Market  Research  Methodology 13
1.2.2  Market  Assumption 14
1.2.3  Secondary  Data 14
1.2.4  Primary  Data 14
1.2.5  Data  Filtration  and  Model  Design 15
1.2.6  Market  Size/Share  Estimation 16
1.2.7  Research  Limitations 17
1.3  Executive  Summary 18
2  Market  Overview  and  Dynamics 20
2.1  Market  Size  and  Forecast 20
2.1.1  Impact  of  COVID-19  on  World  Economy 21
2.1.2  Impact  of  COVID-19  on  the  Market 23
2.2  Major  Growth  Drivers 25
2.3  Market  Restraints  and  Challenges 31
2.4  Emerging  Opportunities  and  Market  Trends 34
2.5  Porter’s  Fiver  Forces  Analysis 38
3  Segmentation  of  Global  Market  by  Product  Type 42
3.1  Market  Overview  by  Product  Type 42
3.2  Implantable  Bioelectric  Medicine 44
3.2.1  Cardiac  Pacemaker 46
3.2.2  Implantable  Cardioverter  Defibrillators  (ICD) 47
3.2.3  Spinal  Cord  Stimulators 48
3.2.4  Cochlear  Implants 49
3.2.5  Deep  Brain  Stimulators 50
3.2.6  Vagus  Nerve  Stimulators 51
3.2.7  Sacral  Nerve  Stimulators 52
3.2.8  Retinal  Implants 53
3.2.9  Other  Implantable  Bioelectric  Medicines 54
3.3  Non-invasive  Bioelectric  Medicine 55
3.3.1  Transcutaneous  Electrical  Nerve  Stimulators 57
3.3.2  Transcranial  Magnetic  Stimulation  (TMS) 58
3.3.3  Pulsed  Electromagnetic  Field  Therapy 59
3.3.4  Other  Non-invasive  Bioelectric  Medicines 60
4  Segmentation  of  Global  Market  by  End  User 61
4.1  Market  Overview  by  End  User 61
4.2  Hospitals  and  Clinics 63
4.3  Research  Institutes 64
4.4  Individual  Users 65
5  Segmentation  of  Global  Market  by  Region 66
5.1  Geographic  Market  Overview  2020-2030 66
5.2  North  America  Market  2020-2030  by  Country 72
5.2.1  Overview  of  North  America  Market 72
5.2.2  U.S. 76
5.2.3  Canada 82
5.2.4  Mexico 84
5.3  European  Market  2020-2030  by  Country 86
5.3.1  Overview  of  European  Market 86
5.3.2  Germany 90
5.3.3  UK 92
5.3.4  France 94
5.3.5  Spain 96
5.3.6  Italy 98
5.3.7  Russia 100
5.3.8  Rest  of  European  Market 102
5.4  Asia-Pacific  Market  2020-2030  by  Country 104
5.4.1  Overview  of  Asia-Pacific  Market 104
5.4.2  Japan 108
5.4.3  China 111
5.4.4  Australia 113
5.4.5  India 115
5.4.6  South  Korea 117
5.4.7  Rest  of  APAC  Region 119
5.5  South  America  Market  2020-2030  by  Country 121
5.5.1  Argentina 124
5.5.2  Brazil 126
5.5.3  Chile 128
5.5.4  Rest  of  South  America  Market 130
5.6  MEA  Market  2020-2030  by  Country 131
5.6.1  UAE 134
5.6.2  Saudi  Arabia 136
5.6.3  South  Africa 138
5.6.4  Other  National  Markets 140
6  Competitive  Landscape 141
6.1  Overview  of  Key  Vendors 141
6.2  New  Product  Launch,  Partnership,  Investment,  and  M&A 147
6.3  Company  Profiles 148
Abbott  Laboratories 148
BIOTRONIK  SE  &  Co.  KG 151
Boston  Scientific  Corporation 155
Cochlear  Limited 159
electroCore,  Inc. 162
Inspire  Medical  Systems,  Inc. 164
LivaNova  PLC 166
Medtronic  PLC 168
NeuroMetrix,  Inc 172
Nevro  Corp. 174
Nuvectra  Corporation 176
OMRON  CORPORATION 178
Pixium  Vision 181
Second  Sight  Medical  Products  Inc 184
SetPoint  Medical 187
Sonova  Holding  AG 189
St.  Jude  Medical,  Inc. 191
Stimwave  LLC 193
7  Investing  in  Global  Market:  Risk  Assessment  and  Management 195
7.1  Risk  Evaluation  of  Global  Market 195
7.2  Critical  Success  Factors  (CSFs) 198
Related  Reports  and  Products 201
For more information, please contact [email protected]
 Feel free to contact us

 
Choose License Type
Select User Type


Report code




x

Use Code

SDMR20

Purchase any report

AVAIL FLAT DISCOUNT